Literature DB >> 27475737

Rapid molecular determination of methicillin resistance in staphylococcal bacteraemia improves early targeted antibiotic prescribing: a randomized clinical trial.

S Emonet1, P G Charles2, S Harbarth3, A J Stewardson2, G Renzi4, I Uckay3, A Cherkaoui4, M Rougemont3, J Schrenzel5.   

Abstract

Empiric therapy of methicillin-susceptible Staphylococcus aureus (MSSA) infections with vancomycin is associated with poorer outcome than targeted therapy with β-lactams. Our objective was to evaluate whether rapid determination of methicillin resistance shortens the time from Gram stain to targeted antimicrobial therapy in staphylococcal bacteraemia, thereby reducing vancomycin overuse. This was a single-centre open parallel RCT. Gram-positive cocci in clusters in positive blood culture underwent real-time PCR for rapid species and methicillin resistance determination parallel to conventional microbiology. Patients were randomized 1:1 so that clinicians would be informed of PCR results (intervention group) or not (control group). Eighty-nine patients (intervention 48, control 41) were analysed. MRSA was identified in seven patients, MSSA in 46, and CoNS in 36. PCR results were highly concordant (87/89) with standard microbiology. Median time (hours) from Gram stain to transmission of methicillin-susceptibility was 3.9 (2.8-4.3) vs. 25.4 (24.4-26-7) in intervention vs. control groups (p <0.001). Median time (hours) from Gram stain to targeted treatment was similar for 'all staphylococci' [6 (3.8-10) vs. 8 (1-36) p 0.13] but shorter in the intervention group when considering S. aureus only [5 (3-7) vs. 25.5 (3.8-54) p <0.001]. When standard susceptibility testing was complete, 41/48 (85.4%) patients in the intervention group were already receiving targeted therapy compared with 23/41 (56.1%) in the control group (p 0.004). There was no significant effect on clinical outcomes. Rapid determination of methicillin resistance in staphylococcal bacteraemia is accurate and reduces significantly the time to targeted antibiotic therapy in the subgroup of S. aureus, thereby avoiding unnecessary exposure to vancomycin.
Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial stewardship; Methicillin resistance; Molecular diagnosis; Rapid microbiology; Staphylococcal bacteraemia; Targeted treatment

Mesh:

Substances:

Year:  2016        PMID: 27475737     DOI: 10.1016/j.cmi.2016.07.022

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  5 in total

Review 1.  [Advances in diagnostic microbiology : Opportunities and limitations].

Authors:  F P Maurer; M Hentschke; H Rohde
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-03-24       Impact factor: 0.840

Review 2.  Advances in Rapid Identification and Susceptibility Testing of Bacteria in the Clinical Microbiology Laboratory: Implications for Patient Care and Antimicrobial Stewardship Programs.

Authors:  Florian P Maurer; Martin Christner; Moritz Hentschke; Holger Rohde
Journal:  Infect Dis Rep       Date:  2017-03-30

3.  Detection of Methicillin-Resistant Staphylococcus aureus Infections Using Molecular Methods.

Authors:  Fred C Tenover; Isabella A Tickler
Journal:  Antibiotics (Basel)       Date:  2022-02-12

4.  Antimicrobial susceptibility testing for Gram positive cocci towards vancomycin using scanning electron microscopy.

Authors:  Sara Bellali; Gabriel Haddad; Rim Iwaza; Anthony Fontanini; Akiko Hisada; Yusuke Ominami; Didier Raoult; Jacques Bou Khalil
Journal:  Curr Res Microb Sci       Date:  2022-07-02

5.  Rapid versus standard antimicrobial susceptibility testing to guide treatment of bloodstream infection.

Authors:  Vanesa Anton-Vazquez; Paul Hine; Sanjeev Krishna; Marty Chaplin; Timothy Planche
Journal:  Cochrane Database Syst Rev       Date:  2021-05-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.